PT863901E - Antibiotico carbapenem composicao e metodo de preparacao - Google Patents

Antibiotico carbapenem composicao e metodo de preparacao

Info

Publication number
PT863901E
PT863901E PT97925725T PT97925725T PT863901E PT 863901 E PT863901 E PT 863901E PT 97925725 T PT97925725 T PT 97925725T PT 97925725 T PT97925725 T PT 97925725T PT 863901 E PT863901 E PT 863901E
Authority
PT
Portugal
Prior art keywords
preparation
composition
antibiotic carbapenem
carbapenem
antibiotic
Prior art date
Application number
PT97925725T
Other languages
English (en)
Portuguese (pt)
Inventor
Daniel R Sidler
John M Williams
William A Hunke
Michael J Kaufman
Jeffrey A Zimmerman
Pal A Bergquist
Lisa M Dimichele
David C Dubost
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9612668.5A external-priority patent/GB9612668D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PT863901E publication Critical patent/PT863901E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97925725T 1996-05-28 1997-05-23 Antibiotico carbapenem composicao e metodo de preparacao PT863901E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1851896P 1996-05-28 1996-05-28
GBGB9612668.5A GB9612668D0 (en) 1996-06-18 1996-06-18 Carbapenem antibiotic composition and method of preparation

Publications (1)

Publication Number Publication Date
PT863901E true PT863901E (pt) 2004-02-27

Family

ID=26309530

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97925725T PT863901E (pt) 1996-05-28 1997-05-23 Antibiotico carbapenem composicao e metodo de preparacao

Country Status (33)

Country Link
EP (1) EP0863901B1 (enExample)
JP (2) JPH11509871A (enExample)
KR (2) KR100403497B1 (enExample)
CN (1) CN1067074C (enExample)
AT (1) ATE252584T1 (enExample)
AU (1) AU710102B2 (enExample)
BG (1) BG63821B1 (enExample)
CA (1) CA2227994C (enExample)
CO (1) CO4940412A1 (enExample)
CY (1) CY2437B1 (enExample)
CZ (1) CZ296381B6 (enExample)
DE (1) DE69725696T2 (enExample)
DK (1) DK0863901T3 (enExample)
DZ (1) DZ2242A1 (enExample)
EA (1) EA000534B1 (enExample)
EE (1) EE04678B1 (enExample)
ES (1) ES2208907T3 (enExample)
HR (1) HRP970281B1 (enExample)
HU (1) HU229426B1 (enExample)
ID (1) ID16974A (enExample)
IL (1) IL123078A (enExample)
IS (1) IS2353B (enExample)
MX (1) MX9800808A (enExample)
NO (1) NO323815B1 (enExample)
NZ (1) NZ329649A (enExample)
PL (1) PL188917B1 (enExample)
PT (1) PT863901E (enExample)
RS (1) RS49583B (enExample)
SI (1) SI0863901T1 (enExample)
SK (1) SK284359B6 (enExample)
TR (1) TR199800146T1 (enExample)
TW (1) TW434014B (enExample)
WO (1) WO1997045430A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0937079A4 (en) * 1996-10-28 2001-01-24 Merck & Co Inc STABILIZED ANTIBIOTIC CARBAPENEM COMPOSITIONS AND A METHOD FOR THEIR PRODUCTION
US6180783B1 (en) * 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
WO1998057973A1 (en) * 1997-06-16 1998-12-23 Merck & Co., Inc. Stabilized carbapenem intermediates and synthetic use
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
DE60017194T2 (de) * 1999-10-29 2005-12-22 Merck & Co., Inc. Verfahren zur herstellung von carbapenem-antibiotika zubereitungen
AR035728A1 (es) 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
CN101357918B (zh) * 2007-06-22 2011-05-18 山东轩竹医药科技有限公司 含有异硫脲基巯基吡咯烷的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
WO2009075309A1 (ja) 2007-12-12 2009-06-18 Dainippon Sumitomo Pharma Co., Ltd. 製剤組成物
CN101550138B (zh) * 2008-04-03 2011-05-18 山东轩竹医药科技有限公司 巯基氮杂环烷酰胺醇取代的培南衍生物
WO2009150630A2 (en) * 2008-06-11 2009-12-17 Ranbaxy Laboratories Limited Process for preparing a carbapenem antibiotic composition
CN102365266B (zh) 2009-03-31 2013-11-06 三菱综合材料株式会社 含氟n-烷基磺酰亚胺化合物及其制造方法、以及离子性化合物的制造方法
BRPI1014338B1 (pt) 2009-06-25 2019-12-24 Shell Int Research método para injetar água em uma formação contendo hidrocarbonetos, e, método para preparar uma água com salinidade elevada
WO2012047832A2 (en) 2010-10-07 2012-04-12 Shell Oil Company Process for the production of alcohols from biomass
WO2012061596A1 (en) 2010-11-05 2012-05-10 Shell Oil Company Treating biomass to produce materials useful for biofuels
WO2012088108A1 (en) 2010-12-20 2012-06-28 Shell Oil Company Process for the production of alcohols from biomass
EP2791344B1 (en) 2011-12-15 2016-02-24 Shell Internationale Research Maatschappij B.V. Method of treating byproducts from ethanol production
US20130309739A1 (en) 2012-05-17 2013-11-21 Shell Oil Company Methods and systems for processing biomass material
CN103860485A (zh) * 2012-12-18 2014-06-18 深圳市海滨制药有限公司 一种厄他培南钠冻干制剂及其制备方法
EP3132045A1 (en) 2014-04-17 2017-02-22 Shell Internationale Research Maatschappij B.V. Processes for producing fermentation products
EP3180320B1 (en) 2014-08-14 2021-01-13 Shell International Research Maatschappij B.V. Process for preparing furfural from biomass

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8502863A1 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds

Also Published As

Publication number Publication date
NO980380L (no) 1998-03-16
HK1016176A1 (en) 1999-10-29
SI0863901T1 (en) 2004-04-30
RS49583B (sr) 2007-04-10
SK284359B6 (sk) 2005-02-04
NO323815B1 (no) 2007-07-09
IL123078A (en) 2002-03-10
IS2353B (is) 2008-04-15
CN1198162A (zh) 1998-11-04
DZ2242A1 (fr) 2002-12-18
KR100344479B1 (ko) 2002-10-31
EP0863901B1 (en) 2003-10-22
HU229426B1 (en) 2013-12-30
WO1997045430A1 (en) 1997-12-04
EE04678B1 (et) 2006-08-15
JP5255983B2 (ja) 2013-08-07
IS4663A (is) 1998-01-27
ES2208907T3 (es) 2004-06-16
CO4940412A1 (es) 2000-07-24
PL324746A1 (en) 1998-06-08
TR199800146T1 (xx) 1998-06-22
ID16974A (id) 1997-11-27
EE9800022A (et) 1998-08-17
CZ296381B6 (cs) 2006-03-15
YU4198A (sh) 1998-12-23
CY2437B1 (en) 2004-11-12
EA199800180A1 (ru) 1998-08-27
ATE252584T1 (de) 2003-11-15
KR19990036052A (enExample) 1999-05-25
DE69725696T2 (de) 2004-07-29
JP2009084284A (ja) 2009-04-23
DE69725696D1 (de) 2003-11-27
HUP9901567A3 (en) 2000-03-28
BG63821B1 (bg) 2003-02-28
CA2227994A1 (en) 1997-12-04
CN1067074C (zh) 2001-06-13
KR100403497B1 (ko) 2003-10-30
HRP970281A2 (en) 1998-06-30
NZ329649A (en) 1998-11-25
MX9800808A (es) 1998-04-30
EP0863901A1 (en) 1998-09-16
DK0863901T3 (da) 2004-02-16
AU710102B2 (en) 1999-09-16
JPH11509871A (ja) 1999-08-31
SK10998A3 (en) 1998-08-05
AU3077597A (en) 1998-01-05
HUP9901567A2 (hu) 1999-09-28
CA2227994C (en) 2002-06-25
EA000534B1 (ru) 1999-10-28
BG102273A (bg) 1998-09-30
CZ25398A3 (cs) 1998-07-15
PL188917B1 (pl) 2005-05-31
HRP970281B1 (en) 2002-04-30
IL123078A0 (en) 1998-09-24
NO980380D0 (no) 1998-01-28
TW434014B (en) 2001-05-16

Similar Documents

Publication Publication Date Title
DK0863901T3 (da) Carbapenemantibiotikum, sammensætning og fremgangsmåde til fremstilling
AU6645998A (en) Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
AU6114699A (en) Naphthrydine compounds and their azaisosteric analogues as antibacterials
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
AU3215597A (en) Method of inhibiting fibrosis with a somatostatin agonist
AU4064597A (en) Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
BG103474A (en) Application of derivatives of 7-(2-oxa-5,8-diazobicyclo[4,3,0]non-8-8-yl)-quinoloncarboxylic acid and naphthyridoncarboxylic acid in the therapy of helicobacter pylor infections and the gastroduodenal diseases related to them
UA29435C2 (uk) Похідні 3бета-алкенілпенаму та їх фармацевтично прийнятні солі
AU5727899A (en) Diaminocyclobutene-3,4-dione derivatives, their preparation and use
ZA974573B (en) Carbapenem antibiotic, composition and method of preparation.
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
AU2881399A (en) N1-modified glycopeptides
MY116202A (en) Carbapenem antibiotic, composition and method of preparation
ECSP972136A (es) Composicion y metodo de preparacion de un antibiotico de carbapemen
EP0937718A4 (en) ANTIBIOTIC TKR2648 AND PROCESS FOR PRODUCING THE SAME
MX9804797A (es) Nuevos compuestos con efecto analgesico.
MX9804798A (es) Nuevos compuestos con efecto analgesico.